Home NDC 65862-312 Didanosine
Product NDC 65862-312
11-digit product format 658620312
Labeler code 65862
Product ID 65862-312_e8187d15-dc5b-4f8f-903c-cf1733d9a135
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Didanosine
Dosage form CAPSULE, DELAYED RELEASE
Route ORAL
Labeler Aurobindo Pharma Limited
Application ANDA090094
Marketing category ANDA
Marketing start 2008-09-24
Marketing end 0000-00-00
Substance DIDANOSINE
Active strength 250 mg/1
Pharmacologic classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 65862-312-05 65862031205 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-312-05) 2008-09-24 0000-00-00 No No Current 65862-312-10 65862031210 10 BLISTER PACK in 1 CARTON (65862-312-10) > 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK 10 blister pack 2008-09-24 0000-00-00 No No Current 65862-312-30 65862031230 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-312-30) 2008-09-24 0000-00-00 No No Current